Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

No clear link between androgen receptor variation and hair loss, but more research needed.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Finasteride helps treat hair loss by blocking enzyme activity.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

AR polyglycine repeat doesn't cause baldness.

Testosterone may slow down wound healing and increase inflammation.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

Melatonin applied to the scalp helps increase hair density in people with early hair loss.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A new gene, JMJD1C, may affect testosterone levels in men.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.